Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated beats earnings expectations. Reported EPS is $-1.05817, expectations were $-1.21. Insmed Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […]
A Detailed Look at Insmed's Financial Performance and Strategic Clinical Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.